Loading clinical trials...

Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance. | Clinical Trials | Clareo Health

COMPLETEDNA

Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.

A Single-Group Clinical Trial to Evaluate the Effect of an Oral Supplement to Provide Relief From Symptoms of Hormonal Imbalance.

NCT06535698•Perelel Inc.

View on ClinicalTrials.gov

Summary

This is a virtual single-group trial lasting 12 weeks to evaluate the effects of Perelel Health's hormonal balance support on symptoms of hormonal imbalance and overall menstrual health.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Self-reported symptoms of hormonal imbalance (e.g., mood swings, irregular menstrual cycles)
•Generally healthy without uncontrolled chronic diseases
•Willing to avoid new hormonal balance treatments during the study
•Consistent use of current hormonal balance treatments for at least 3 months prior to the study

Exclusion Criteria

•Chronic conditions preventing adherence to the protocol Diabetes
•Planned hormonal balance-related procedures during the study
•Started any new medications or supplements that target hormonal balance in the past 3 months
•Anyone with diabetes
•Severe allergies requiring EpiPen
•Pregnant, breastfeeding, or trying to conceive
•Recent surgeries or planned surgeries during the study
•Unwilling to follow the study protocol

Locations (1)

Citruslabs

Santa Monica, California, United States

Key Dates

Start Date

February 19, 2024

Primary Completion Date

June 10, 2024

Completion Date

June 10, 2024

Last Updated

August 2, 2024

Enrollment

ACTUAL participants

Conditions

Women's Health

Interventions

Perelel Health Hormonal Balance Support

DIETARY_SUPPLEMENT

Contribution of Virtual Reality in the Management of Patients Undergoing Scheduled Cesarean Section - VR-SCS

NCT06622408

Women's HealthPerinatal Care+2 more

View study

ACTIVE_NOT_RECRUITINGNA

Co-Developing an HIV Prevention Program for Women in Ghana

NCT07003789

HIV PreventionWomen's Health+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.

Inclusion Criteria

Exclusion Criteria

Contribution of Virtual Reality in the Management of Patients Undergoing Scheduled Cesarean Section - VR-SCS

Co-Developing an HIV Prevention Program for Women in Ghana

Effects of Virtual Reality and Nature Sounds on Pain and Anxiety During Hysterosalpingography

Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women

Collection and Distribution of Biospecimens for Novel Research

Hybrid Training and Middle Age